OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
09 févr. 2023 08h30 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Feb. 09, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx CEO Issues Open Letter to Shareholders Ahead of Presentation at J.P. Morgan Healthcare Conference
04 janv. 2023 07h30 HE
|
OptimizeRx Corporation
OPRX CEO Will Febbo provides business update and key industry trendsOPRX conference presentation to begin at 8:15 AM PT on January 12, 2023 ROCHESTER, Mich., Jan. 04, 2023 (GLOBE NEWSWIRE) --...
OptimizeRx to Participate in Upcoming Investor Conferences
28 nov. 2022 09h31 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Nov. 28, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports Third Quarter 2022 Financial Results
08 nov. 2022 16h01 HE
|
OptimizeRx Corporation
Q3 Revenue of $15.1 million, down 6% year-over-year and up 8% quarter-over-quarterGross profit increased 4% year-over-year to $9.4 million as gross margins increased from 56% to 62%Generated $7.9...
OptimizeRx and Melinta Therapeutics Present Third Annual Innovate4Outcomes(R) Healthcare Design Thinking-Inspired Event
20 oct. 2022 09h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets Third Quarter Fiscal 2022 Conference Call for Tuesday, November 8 at 4:30 p.m. ET
19 oct. 2022 16h05 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Announces Strong Results from its use of Previously Announced AI/RWE Solution
11 oct. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Oct. 11, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Extends Exclusive Partnership with ePrescribing Leader Therapy Brands
20 sept. 2022 08h00 HE
|
OptimizeRx Corporation
Innovative best-in-class technology solutions continue to offer HCPs a seamless prescribing experience within the EHR workflow ROCHESTER, Mich., Sept. 20, 2022 (GLOBE NEWSWIRE) -- OptimizeRx...
OptimizeRx to Participate in Upcoming September Conferences
07 sept. 2022 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports Results of Flagship Evidence-Based Physician Engagement Program
23 août 2022 09h18 HE
|
OptimizeRx Corporation
Analysis finds patent-pending real-world evidence solution successful in identifying HCPs with patients at risk of non-adherence due to unexpected cost. Proactive affordability messaging key for...